NCT04226963[Secondary Source ID] - Search Results

Your saved search

Your RSS Feed

Year	Number of Results
2021	2
2025	1
2026	0

Page 1

Nonresponse to Ketamine in Treatment-Resistant Bipolar Depression.

Kachlik Z, Cubała WJ, Walaszek M, Pastuszak M, Pastuszak K, Kwaśny A. Kachlik Z, et al. Neuropsychopharmacol Rep. 2025 Sep;45(3):e70038. doi: 10.1002/npr2.70038. Neuropsychopharmacol Rep. 2025. PMID: 40879542 Free PMC article.

Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study.

Włodarczyk A, Cubała WJ, Gałuszko-Węgielnik M, Szarmach J. Włodarczyk A, et al. Medicine (Baltimore). 2021 Jul 23;100(29):e26769. doi: 10.1097/MD.0000000000026769. Medicine (Baltimore). 2021. PMID: 34398056 Free PMC article.

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression.

Włodarczyk A, Cubała WJ, Gałuszko-Węgielnik M, Szarmach J. Włodarczyk A, et al. Ther Adv Psychopharmacol. 2021 May 19;11:20451253211011021. doi: 10.1177/20451253211011021. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 34046159 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year